Ryan White Center for Pediatric Infectious Disease and Global Health, Indiana University School of Medicine, R4-402D 1044 W. Walnut St., Indianapolis, IN, 46202, USA.
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Fluids Barriers CNS. 2024 May 1;21(1):38. doi: 10.1186/s12987-024-00541-9.
BACKGROUND: Blood-brain barrier (BBB) disruption is a central feature of cerebral malaria (CM), a severe complication of Plasmodium falciparum (Pf) infections. In CM, sequestration of Pf-infected red blood cells (Pf-iRBCs) to brain endothelial cells combined with inflammation, hemolysis, microvasculature obstruction and endothelial dysfunction mediates BBB disruption, resulting in severe neurologic symptoms including coma and seizures, potentially leading to death or long-term sequelae. In vitro models have advanced our knowledge of CM-mediated BBB disruption, but their physiological relevance remains uncertain. Using human induced pluripotent stem cell-derived brain microvascular endothelial cells (hiPSC-BMECs), we aimed to develop a novel in vitro model of the BBB in CM, exhibiting enhanced barrier properties. METHODS: hiPSC-BMECs were co-cultured with HB3var03 strain Pf-iRBCs up to 9 h. Barrier integrity was measured using transendothelial electrical resistance (TEER) and sodium fluorescein permeability assays. Localization and expression of tight junction (TJ) proteins (occludin, zonula occludens-1, claudin-5), cellular adhesion molecules (ICAM-1, VCAM-1), and endothelial surface markers (EPCR) were determined using immunofluorescence imaging (IF) and western blotting (WB). Expression of angiogenic and cell stress markers were measured using multiplex proteome profiler arrays. RESULTS: After 6-h of co-culture with Pf-iRBCs, hiPSC-BMECs showed reduced TEER and increased sodium fluorescein permeability compared to co-culture with uninfected RBCs, indicative of a leaky barrier. We observed disruptions in localization of occludin, zonula occludens-1, and claudin-5 by IF, but no change in protein expression by WB in Pf-iRBC co-cultures. Expression of ICAM-1 and VCAM-1 but not EPCR was elevated in hiPSC-BMECs with Pf-iRBC co-culture compared to uninfected RBC co-culture. In addition, there was an increase in expression of angiogenin, platelet factor-4, and phospho-heat shock protein-27 in the Pf-iRBCs co-culture compared to uninfected RBC co-culture. CONCLUSION: These findings demonstrate the validity of our hiPSC-BMECs based model of the BBB, that displays enhanced barrier integrity and appropriate TJ protein localization. In the hiPSC-BMEC co-culture with Pf-iRBCs, reduced TEER, increased paracellular permeability, changes in TJ protein localization, increase in expression of adhesion molecules, and markers of angiogenesis and cellular stress all point towards a novel model with enhanced barrier properties, suitable for investigating pathogenic mechanisms underlying BBB disruption in CM.
背景:血脑屏障(BBB)破坏是恶性疟原虫(Pf)感染引起的严重并发症——脑型疟疾(CM)的一个核心特征。在 CM 中,Pf 感染的红细胞(Pf-iRBC)与脑内皮细胞的嵌顿,加上炎症、溶血、微血管阻塞和内皮功能障碍,导致 BBB 破坏,从而引发严重的神经症状,包括昏迷和癫痫发作,这可能导致死亡或长期后遗症。体外模型已经提高了我们对 CM 介导的 BBB 破坏的认识,但它们的生理相关性仍不确定。本研究使用人诱导多能干细胞衍生的脑微血管内皮细胞(hiPSC-BMEC),旨在开发一种具有增强屏障特性的 CM 中 BBB 的新型体外模型。
方法:将 hiPSC-BMEC 与 HB3var03 株 Pf-iRBC 共培养长达 9 小时。通过跨内皮电阻(TEER)和钠离子荧光素通透性测定来测量屏障完整性。使用免疫荧光成像(IF)和蛋白质印迹(WB)测定紧密连接(TJ)蛋白(occludin、zonula occludens-1、claudin-5)、细胞黏附分子(ICAM-1、VCAM-1)和内皮表面标志物(EPCR)的定位和表达。使用多重蛋白质谱分析测定血管生成和细胞应激标志物的表达。
结果:与未感染 RBC 共培养相比,Pf-iRBC 共培养 6 小时后,hiPSC-BMEC 的 TEER 降低,钠离子荧光素通透性增加,表明屏障通透性增加。IF 观察到 occludin、zonula occludens-1 和 claudin-5 的定位中断,但 WB 显示 Pf-iRBC 共培养中这些蛋白的表达没有变化。与未感染 RBC 共培养相比,hiPSC-BMEC 中 ICAM-1 和 VCAM-1 的表达升高,而 EPCR 的表达没有升高。与未感染 RBC 共培养相比,Pf-iRBC 共培养中血管生成素、血小板因子 4 和磷酸化热休克蛋白 27 的表达增加。
结论:这些发现证明了我们基于 hiPSC-BMEC 的 BBB 模型的有效性,该模型显示出增强的屏障完整性和适当的 TJ 蛋白定位。在 hiPSC-BMEC 与 Pf-iRBC 的共培养中,TEER 降低、细胞旁通透性增加、TJ 蛋白定位改变、黏附分子表达增加以及血管生成和细胞应激标志物的表达均指向一种具有增强屏障特性的新型模型,适合研究 CM 中 BBB 破坏的致病机制。
Fluids Barriers CNS. 2024-5-1
Fluids Barriers CNS. 2017-4-13
Methods Mol Biol. 2022
Int J Mol Sci. 2025-4-11
Front Cell Neurosci. 2022-5-11
Front Aging Neurosci. 2021-9-28
J Clin Invest. 2020-3-2